Product NewsElectrophoretic fingerprinting of HIV/AIDS virus – another first for the Malvern Zetasizer Nano
Product NewsSYMPHOGEN’S SUCCESS IN MANUFACTURING CONSISTENT BATCHES OF POLYCLONAL ANTIBODIES FOR CLINICAL TRIALS ATTRACTS NEW USD 25 MILLION INVESTMENT